ArticleFrontiers in medicine2026
Diagnostic accuracy of artificial intelligence in detection of ovarian cancer-a pilot study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate a panel of variables using four machine learning based classifiers, i.e., support vector machine (SVM), random forest (RF), artificial neural network (ANN) and logistic regression (LR) to make a diagnosis of ovarian cancer, differentiating it from benign ovarian masses. Materials and methods: A prospective observational pilot study was done between November 2021 and June 2023. Following data pre-processing to ensure compatibility with ML models, four ML algorithms, i.e., support vector machine (SVM), logistic regression (LR), random forest (RF) and artificial neural network (ANN) were tested by multimodal parameters from the datasets of 50 patients presenting with suspected epithelial ovarian cancer (Group A) or benign ovarian tumour (Group B). Statistical analysis was done using STATA version 14.0. Results: We found that the machine learning approach could predict malignant tumours with appreciably high accuracy similar to a few studies done so far in this field. All four ML algorithms showed high level of accuracy with a maximum AUROC of 0.92 in the RF model. Both RF and SVM had an accuracy of 85.87 and 83.05%. Conclusion: The ML algorithms can detect ovarian cancers with a high level of accuracy. Further, a large-volume prospective study on large volume data sets is required before inclusion of ML algorithms in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.